Why Medtech Giants Are Quietly Paying Up for AI Diagnostics
A bidding war for AI diagnostics is driving growth in the medical imaging market, which is expected to reach $2.20 billion by 2026. Companies like VentriPoint Diagnostics, which recently won a Gold Medal at the Edison Awards for its AI-powered cardiac imaging platform, are leading the charge. Hospitals prioritize AI clinical solutions, and institutional buyers are willing to pay a premium for platforms with solid clinical validation. Medtronic also expanded its portfolio by acquiring CathWorks, which enhances its offerings in interventional cardiology.
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, April 29, 2026 /PRNewswire/ — USANewsGroup.com News Commentary – There’s a quiet bidding war underway for AI diagnostics, and the price keeps climbing. The global AI in medical imaging market is on track to hit $2.20 billion…